
Esat Korgali
@estkorgali
Elif’in Eşi, Ayşe Defne, Ahmet, Madran’ın Babası, CTF2000, İÜTFÜroloji 2006 , Prof. Dr.,SCÜTF Üroloji AD Bşk.
ID: 161231727
30-06-2010 09:22:58
4,4K Tweet
413 Followers
876 Following






#AUA25 Amer. Urol. Assn. SMU México Biomarkers in Urolithiasis: How could they improve our practice? @ Brian Eisner Postoperative sepsis in urology is not rare. Procalcitonin is a promising marker. QSOFA outperforms SIRS in predicting sepsis, ER visits, and readmissions. More



Y Brian Eisner 👉🏼SURE Steerable Ureteroscopic Renal Evacuation device 👨🔬A promising innovation with an excellent stone-free rate. Although it currently requires a 12-14 Fr access sheath, future generations will likely optimize its profile. #AUA25

Upfront cytoreductive nephrectomy with deferred systemic therapy for metastatic #RenalCellCarcinoma. Presentation by Bimal Bhindi U Calgary. #AUA25 written coverage by Harel Sims UC Irvine > bit.ly/42OoIZv Amer. Urol. Assn.


Oh. My. God. Look. At. This. Data. 11 million women w recurrent uti. If using vaginal estrogen 73% less MORTALITY 51% less SEPSIS 22% less hospitalizations 📉 the graphs don’t lie Elise J.B. De, MD should get a Nobel prize for this work #AUA25 Ashley Winter MD || Urologist


Impressive early RCT findings - repetitive transcranial magnetic stimulation (rTMS) for MS pts w refractory NOAB 🔘 fMRI-mapped 🧠 probe 🔘 10 x 40 min rTMS vs Sham 🔘 ⬆️ NOAB symptoms 🔘 ⬇️ PVR Exciting glimpse into future tx paradigm Rose Khavari MD Houston Methodist Urology and Residency Program #aua25


Impact of cytoreductive nephrectomy on immune checkpoint inhibitor therapy: treatment outcomes of immune inhibitor combination therapies for metastatic #RenalCellCarcinoma with primary kidney tumors. Presentation by Toshio Takagi, MD, PhD. #AUA25 written coverage by Zach Klaassen


Patient with high-risk #NMIBC: balancing BCG with new and emerging treatments in the era of personalized medicine. #IBCGBladderCancerForum Presentation by Joshua Meeks and Benjamin Pradere. #AUA25 written coverage by Zach Klaassen > bit.ly/4cVcD9M Amer. Urol. Assn.



#BladderCancer incidence and plastics-processing waste release in #Ohio: Are microplastics a novel risk factor? Presentation by Laura Elizabeth Davis, MD. #AUA25 written coverage by Yezan Hadidi > bit.ly/4cVtVUe Amer. Urol. Assn.


Renal mass biopsy for small renal masses: a single center 20-year experience. Presentation by Lucshman Raveendran Univ of Toronto Urology. #AUA25 written coverage by Tiffany Huang UC Irvine > bit.ly/4iDwdZa Amer. Urol. Assn.



Game-changer in prostate cancer risk stratification! PSMA-PET isn’t just for staging—it predicts survival. European Urology Advanced Prostate Cancer Consensus Conference European Association of Urology (EAU) Prostate Cancer Foundation Ken Herrmann Michael Hofman doi.org/10.1016/j.euru…


New IBCG consensus on bladder preservation for MIBC: 🔵TMT = main RC alternative 🔵Best for cT2, unifocal, no CIS/hydronephrosis 🔵Multidisciplinary eval is key 🔵Other options = only for highly selected patients European Urology European Association of Urology (EAU) ESMO - Eur. Oncology Shilpa Gupta Prof Ananya💙 @achoud72.bsky.social Sia Daneshmand, M.D.

